Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
Cartridges of this lot of oxoid antimicrobial susceptibility testing discs may contain discs with insufficient amount of antibiotic resulting in smaller than expected zones of inhibition. continued use of this lot could result in false indication of resistance to meropenem.